Search

Quanterix Corp

Chiusa

SettoreSettore sanitario

3.24 1.89

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.16

Massimo

3.27

Metriche Chiave

By Trading Economics

Entrata

-31M

-49M

Vendite

-3.5M

33M

EPS

-0.45

Margine di Profitto

-148.708

Dipendenti

450

EBITDA

-38M

-49M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-8.26% downside

Dividendi

By Acuity

Utili prossimi

9 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

30M

144M

Apertura precedente

1.35

Chiusura precedente

3.24

Notizie sul Sentiment di mercato

By Acuity

16%

84%

12 / 339 Classifica in Healthcare

Quanterix Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

25 set 2026, 22:50 UTC

Quanterix Corp declined significantly in after-market trading, reversing a slight earlier gain, yet remains above its 20-day moving average and near its one-month range.

24 set 2026, 20:07 UTC

Quanterix Corp's shares traded roughly flat, remaining near unchanged since Wednesday's close while positioned above its 20-day moving average.

18 set 2026, 19:46 UTC

Quanterix Corp shares fell notably during Friday's trading session, with a significant decline around midday before partially recovering, remaining above the 20-day moving average.

17 set 2026, 20:02 UTC

News

Quanterix Corp announced inducement grants totaling 625.64k restricted stock units, contributing to heightened investor interest as shares trade sharply higher.

16 set 2026, 21:11 UTC

Quanterix Corp is advancing in after-market trading, reflecting a modest increase since Wednesday's close and maintaining a trend of three consecutive higher daily closes.

15 set 2026, 20:01 UTC

Quanterix Corp shares are higher during Tuesday's session, maintaining positive momentum despite a broader market decline tied to the NY Empire State Manufacturing Index.

14 set 2026, 20:03 UTC

News

Quanterix Corp appointed Dr. Yuri Fesko as Chief Medical Officer, yet shares are trading lower amid ongoing performance weakness.

11 set 2026, 19:26 UTC

Quanterix Corp shares are higher amid market response to steady inflation data. Earlier, the stock pulled back from a session high before regaining momentum.

10 set 2026, 20:07 UTC

Quanterix Corp shares are lower today, pressured by broader market conditions following the European Central Bank's interest rate hike.

9 set 2026, 20:07 UTC

Quanterix Corp shares are lower today, reaching a session low amid ongoing weakness and trading near the lower end of their one-month range.

8 set 2026, 20:07 UTC

Quanterix Corp shares are higher today, reflecting broader market dynamics amid speculation over a potential Federal Reserve interest rate hike.

4 set 2026, 20:08 UTC

Quanterix Corp shares are higher today, continuing a strong upward trend since Thursday's close, despite broader market pressures from a strong jobs report.

3 set 2026, 20:07 UTC

Quanterix Corp shares are lower today, continuing a decline since Wednesday. The stock is near the lower end of its one-month range.

2 set 2026, 19:46 UTC

Quanterix Corp shares are higher today, though still below their 20-day moving average. Broader market conditions are affected by rising U.S. Treasury yields.

1 set 2026, 20:01 UTC

Quanterix Corp shares are lower today, continuing a decline since Monday. Broader market concerns include rising oil prices and inflation expectations.

31 ago 2026, 19:16 UTC

Quanterix Corp shares are lower amid market anxiety following hawkish remarks from Federal Reserve Chair Kevin Warsh on potential interest rate hikes.

28 ago 2026, 23:41 UTC

Quanterix Corp shares are lower in after-market trading, following a decline earlier in the session amid rising U.S. Treasury yields and falling tech stocks.

24 ago 2026, 20:02 UTC

Quanterix Corp shares are lower today, continuing a decline that began Friday. The stock is near the lower end of its one-month range.

22 ago 2026, 00:02 UTC

Quanterix Corp shares are lower in after-market trading, continuing a decline since Friday's close, with no specific news identified for the movement.

20 ago 2026, 20:06 UTC

Quanterix Corp shares are higher today amid increased market activity. The stock's movement aligns with broader trends, including rising U.S. Treasury yields and crude oil prices.

19 ago 2026, 22:31 UTC

Quanterix Corp shares are higher in after-market trading, reflecting a broader equity rebound after the Treasury's announcement of increased buyback operations for longer-term debt.

18 ago 2026, 23:06 UTC

Quanterix Corp. shares are roughly flat in after-market hours. The stock remains near the lower end of its one-month range.

17 ago 2026, 20:01 UTC

News

Quanterix Corp shares are higher after Director William P. Donnelly's insider purchase of 72,245 shares at $2.93, despite a price target cut by Canaccord Genuity.

14 ago 2026, 23:01 UTC

Quanterix Corp shares are higher in after-market trading, despite no specific news. This follows mixed market sentiment after a decline in U.S. retail sales.

13 ago 2026, 20:02 UTC

Quanterix Corp shares are lower today amid a broader decline in the Life Sciences Tools & Services sub-sector, continuing a downward trend since Wednesday.

12 ago 2026, 23:01 UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

11 ago 2026, 22:51 UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

10 ago 2026, 19:51 UTC

Event
Social Media
News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

7 ago 2026, 19:16 UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

5 ago 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

Confronto tra pari

Modifica del prezzo

Quanterix Corp Previsione

Obiettivo di Prezzo

By TipRanks

-8.26% in calo

Previsioni per 12 mesi

Media 3 USD  -8.26%

Alto 3 USD

Basso 3 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Quanterix Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

2 ratings

0

Acquista

2

Mantieni

0

Vendi

Sentiment

By Acuity

12 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.